| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2017.03.062 |
| P698 | PubMed publication ID | 28366604 |
| P50 | author | L Liu | Q73365179 |
| P2093 | author name string | Hui Wang | |
| Zhiwei Chen | |||
| Ling Chen | |||
| Caijun Sun | |||
| Jia Guo | |||
| Lin Cheng | |||
| Linqi Zhang | |||
| Teng Zuo | |||
| Xian Tang | |||
| P2860 | cites work | Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein | Q39592994 |
| Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops | Q39602333 | ||
| F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis. | Q39692280 | ||
| Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies | Q40106699 | ||
| Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains | Q40621073 | ||
| Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies | Q40682865 | ||
| Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies | Q41621929 | ||
| Production of a murine monoclonal antibody with anti-hiv-1 neutralizing properties | Q41705823 | ||
| Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines | Q42230293 | ||
| Posttranslational modifications within the HIV-1 envelope glycoprotein which restrict virus assembly and CD4-dependent infection | Q44030866 | ||
| Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein. | Q44104909 | ||
| Impact of glycosylation on antigenicity of simian immunodeficiency virus SIV239: induction of rapid V1/V2-specific non-neutralizing antibody and delayed neutralizing antibody following infection with an attenuated deglycosylated mutant | Q45397780 | ||
| A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. | Q52841139 | ||
| Identification of a major co-receptor for primary isolates of HIV-1 | Q22251282 | ||
| Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1 | Q24645530 | ||
| Molecular architectures of trimeric SIV and HIV-1 envelope glycoproteins on intact viruses: strain-dependent variation in quaternary structure | Q27312441 | ||
| Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 | Q27644478 | ||
| Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding | Q27670829 | ||
| Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing | Q27671696 | ||
| A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding | Q28646883 | ||
| Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys | Q28751926 | ||
| Structure of an unliganded simian immunodeficiency virus gp120 core | Q29616089 | ||
| Immune-correlates analysis of an HIV-1 vaccine efficacy trial | Q29617377 | ||
| Distribution and three-dimensional structure of AIDS virus envelope spikes | Q29617562 | ||
| Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes | Q30706865 | ||
| Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody | Q33205911 | ||
| B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4. | Q33373664 | ||
| A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination. | Q33401609 | ||
| Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants | Q33850415 | ||
| Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology | Q33851717 | ||
| Comprehensive analysis of pathogen-specific antibody response in vivo based on an antigen library displayed on surface of yeast | Q33973410 | ||
| Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. | Q33987417 | ||
| Simian immunodeficiency virus infection evades vaccine-elicited antibody responses to V2 region | Q35549289 | ||
| The highly conserved glycan at asparagine 260 of HIV-1 gp120 is indispensable for viral entry | Q35604541 | ||
| Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys | Q35729899 | ||
| CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant | Q35956560 | ||
| Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys | Q36300153 | ||
| Antigenic conservation and immunogenicity of the HIV coreceptor binding site | Q36403587 | ||
| Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys | Q36827361 | ||
| The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1 | Q36839199 | ||
| Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein | Q37207862 | ||
| Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors | Q37388409 | ||
| A three-dimensional model to analyze drug-drug interactions | Q37794779 | ||
| Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac | Q38942816 | ||
| CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity | Q39370718 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Simian immunodeficiency virus | Q1890246 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 2582-2591 | |
| P577 | publication date | 2017-03-31 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Single N277A substitution in C2 of simian immunodeficiency virus envelope influences vaccine-elicited CD4i neutralizing and anti-V2 antibody responses | |
| P478 | volume | 35 |
Search more.